StonvexLoading…
StonvexCore line items from BUR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $94.04M | $-1.72B | $413.36M | $379.95M | $310.14M |
Operating Income | Not available | $-1.57B | $232.11M | $244.77M | $219.98M |
Net Income | Not available | $-1.63B | $62.57M | $100.07M | $119.22M |
EPS (Diluted) | $0.04 | $-7.46 | $0.28 | $0.45 | $0.53 |
Total Assets | Not available | $4.27B | $6.64B | $6.69B | $6.33B |
Total Liabilities | Not available | $2.76B | $3.51B | $3.50B | $3.10B |
Cash & Equivalents | Not available | $702.58M | $566.44M | $677.65M | $372.25M |
Free Cash Flow OCF − CapEx | Not available | $-136.67M | $-29.30M | $50.70M | $70.81M |
Shares Outstanding | Not available | 219.07M | 218.90M | 218.81M | 218.80M |